ALIGATER
"ALIGATER" is a word mark owned by Coave Therapeutics, filed at the USPTO on August 14, 2026. It is under examination and covers classes 5 and 42.
- Status
- Under examination
- Since August 14, 2026
- Filed
- August 14, 2026
- Registered
- Not yet
- Priority date
- February 17, 2026
- Claimed from France
- Application no.
- 50052128
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns ALIGATER
The owner and representative on file with the office.
Owner
Coave Therapeutics
Paris, France
Representative
Pina Campagna
Carter, Deluca, & Farrell, LLP
What the mark covers
The products and services ALIGATER is filed for, grouped by Nice class.
Pharmaceutical preparations in the form of viral systems, gene therapy systems, viral vectors and gene therapy vectors, namely, chemically conjugated viral systems and viral vectors, DNA viruses such as adeno-associated viruses (AAVs) for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Pharmaceutical preparations containing viral vectors for gene therapy; Medicinal preparations for medical, pharmaceutical or veterinary use comprising conjugated viral systems and viral vectors for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Chemical reagents for medical purposes; Chemical reagents for veterinary purposes; Biological reagents for medical purposes; Biological reagents for veterinary purposes; Pharmaceutical preparations for cellular therapy for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Therapeutic biological preparations for use in targeted medical and clinical gene therapy, namely, for ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders, comprising conjugated viral systems and viral vectors; Biological preparations for use in cell cultures for medical purposes
Research and development in the field of biotechnology and targeted gene therapy, namely, research and development based on a platform for the discovery, identification and manufacture of viral systems and vectors chemically conjugated with various types of functional ligands, namely, DNA viruses such as adeno-associated viruses (AAVs); Biological research in the field of conjugated viral systems and viral vectors, targeted gene therapy systems and nucleic acid delivery systems based on conjugated viral systems and viral vectors; Biomedical research in the field of conjugated viral systems and viral vectors, targeted gene therapy systems and nucleic acid delivery systems based on conjugated viral systems and viral vectors; Pharmaceutical research in the field of conjugated viral systems and viral vectors, targeted gene therapy systems and nucleic acid delivery systems based on conjugated viral systems and viral vectors; Research and development in the field of pharmaceuticals relating to conjugated viral systems and viral vectors
What has happened so far
Steps recorded by the USPTO, newest first.
- New application office supplied data entered
- Application filing receipt mailed
- New application entered
About ALIGATER
Who owns the trademark "ALIGATER"?
The USPTO trademark "ALIGATER" (application 50052128) is owned by Coave Therapeutics.
What is the status of "ALIGATER"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull ALIGATER and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a00586-4050-71c9-b0ad-768ecd4fac3d
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a00586-4050-71c9-b0ad-768ecd4fac3d",
"object": "trademark",
"mark_text": "ALIGATER",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50052128",
"filing_date": "2026-08-14",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "COAVE THERAPEUTICS",
"entity_id": null
}
]
}